A comprehensive study of ligand binding to the human PARP family of proteins reveals the molecular basis of inhibitor selectivity and promiscuity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
07 March 2012
In the print version of this article, MD Anderson is listed as Maryland Anderson. The error has been corrected in the HTML and PDF versions of the article before online publication.
References
Jagtap, P. & Szabo, C. Nat. Rev. Drug Discov. 4, 421–440 (2005).
Wahlberg, E. et al. Nat. Biotechnol. 30, 283–288 (2012).
Chambon, P., Weill, J.D. & Mandel, P. Biochem. Biophys. Res. Commun. 11, 39–43 (1963).
Hottiger, M.O., Hassa, P.O., Lüscher, B., Schüler, H. & Koch-Nolte, F. Trends Biochem. Sci. 35, 208–219 (2010).
Kleine, H. et al. Mol. Cell 32, 57–69 (2008).
Huang, S.M. et al. Nature 461, 614–620 (2009).
Fong, P.C. et al. N. Engl. J. Med. 361, 123–134 (2009).
Thomas, H.D. et al. Mol. Cancer Ther. 6, 945–956 (2007).
Penning, T.D. et al. J. Med. Chem. 52, 514–523 (2009).
Shultz, M.D. J. Med. Chem. 55, 1127–1136 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Jones, P. Profiling PARP inhibitors. Nat Biotechnol 30, 249–250 (2012). https://doi.org/10.1038/nbt.2138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2138
This article is cited by
-
Erratum: Profiling PARP inhibitors
Nature Biotechnology (2012)